| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alector, Inc. (ALEC) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 33 sells. ALEC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.42M | $4.55M | - | |
| Pres | 501.7K | $943.1K | - | |
| CFO | 374.3K | $703.7K | - | |
| Dir | 128.1K | $240.8K | - | |
| Other | 104.6K | $196.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2020 | Paul Robert77 | Chief Medical Officer | Sell | 10,000 | $29.61 | $296,137.23 | -2.2% | |
| Jun 3, 2020 | Yu Calvin71 | Vice President, Finance | Sell | 1,343 | $31.26 | $41,980.72 | -0.6% | |
| May 15, 2020 | Paul Robert77 | Chief Medical Officer | Sell | 10,000 | $27.00 | $270,026.12 | -1.4% | |
| May 15, 2020 | King Robert76 | Chief Development Officer | Sell | 15,000 | $27.00 | $404,957.58 | -1.0% | |
| Apr 16, 2020 | Orbimed Advisors LLC67 | 10% Owner | Sell | 85,414 | $23.53 | $2,009,559.11 | -0.5% | |
| Apr 15, 2020 | Paul Robert77 | Chief Medical Officer | Sell | 10,000 | $22.27 | $222,700.00 | -3.9% | |
| Apr 9, 2020 | Orbimed Advisors LLC67 | 10% Owner | Sell | 379,885 | $23.74 | $9,019,570.89 | -1.5% | |
| Mar 31, 2020 | Orbimed Advisors LLC67 | 10% Owner | Sell | 250,000 | $24.50 | $6,125,000.00 | -2.9% | |
| Mar 25, 2020 | Orbimed Advisors LLC67 | 10% Owner | Sell | 138,653 | $24.70 | $3,425,268.96 | -0.5% | |
| Mar 13, 2020 | Paul Robert77 | Chief Medical Officer | Sell | 10,000 | $22.93 | $229,285.52 | -1.0% |